Teleflex Incorporated announced it signed a definitive M&A agreement to acquire substantially all of the assets of LMA International for SGD 343.5 million in cash, which at current exchange rates translates into approximately $276 million.
LMA is a global market leader in laryngeal masks with a portfolio of innovative products used extensively in anesthesia and emergency care.
The Board of Directors of both Teleflex and LMA have approved the proposed M&A transaction, which is subject to LMA shareholder approval, regulatory approvals and other customary closing conditions.
Brown Brothers Harriman & Co. is acting as financial advisor and Simpson Thacher & Bartlett LLP is acting as legal counsel to Teleflex in this M&A transaction.
For further deal information visit Current Agreements (subscription required)
Read: more on M&A deals in pharma, biotech, life science partnering deal news, insights and glossary
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity